Induction of humoral and cellular immune response to hepatitis B virus (HBV) vaccine can be upregulated by CpG oligonucleotides complexed with Dectin-1 ligand
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Induction of humoral and cellular immune response to hepatitis B virus (HBV) vaccine can be upregulated by CpG oligonucleotides complexed with Dectin-1 ligand
Authors
Keywords
-
Journal
JOURNAL OF VIRAL HEPATITIS
Volume 24, Issue 2, Pages 155-162
Publisher
Wiley
Online
2016-11-03
DOI
10.1111/jvh.12629
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibition of induced nitric oxide synthase enhances the anti-tumor effects on cancer immunotherapy using TLR7 agonist in mice
- (2015) Hiroyasu Ito et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Inhibition of indoleamine 2,3-dioxygenase activity enhances the anti-tumour effects of a Toll-like receptor 7 agonist in an established cancer model
- (2015) Hiroyasu Ito et al. IMMUNOLOGY
- Therapeutic efficacy of PD-L1 blockade in a breast cancer model is enhanced by cellular vaccines expressing B7-1 and glycolipid-anchored IL-12
- (2015) Erica N Bozeman et al. Human Vaccines & Immunotherapeutics
- Induction of hepatitis B virus surface antigen-specific cytotoxic T lymphocytes can be up-regulated by the inhibition of indoleamine 2, 3-dioxygenase activity
- (2014) Hiroyasu Ito et al. IMMUNOLOGY
- CXCL9 and CXCL10 Expression Are Critical for Control of Genital Herpes Simplex Virus Type 2 Infection through Mobilization of HSV-Specific CTL and NK Cells to the Nervous System
- (2014) M. Thapa et al. JOURNAL OF IMMUNOLOGY
- Treating Immune-tolerant Hepatitis B
- (2014) T.-C. Tseng et al. JOURNAL OF VIRAL HEPATITIS
- Development of a Novel Severe Triple Allergen Asthma Model in Mice Which Is Resistant to Dexamethasone and Partially Resistant to TLR7 and TLR9 Agonist Treatment
- (2014) Matthias J. Duechs et al. PLoS One
- Nonagonistic Dectin-1 ligand transforms CpG into a multitask nanoparticulate TLR9 agonist
- (2014) K. Kobiyama et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CpG-conjugated apoptotic tumor cells elicit potent tumor-specific immunity
- (2011) Hidekazu Shirota et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Transcriptional regulation by STAT6
- (2011) Shreevrat Goenka et al. IMMUNOLOGIC RESEARCH
- Therapeutic vaccines and immune-based therapies for the treatment of chronic hepatitis B: Perspectives and challenges
- (2011) Marie-Louise Michel et al. JOURNAL OF HEPATOLOGY
- In vitro migration of cytotoxic T lymphocyte derived from a colon carcinoma patient is dependent on CCL2 and CCR2
- (2011) Klara Berencsi et al. Journal of Translational Medicine
- Evaluation of hepatitis B vaccine immunogenicity among older adults during an outbreak response in assisted living facilities
- (2011) Rania A. Tohme et al. VACCINE
- TLR-based immune adjuvants
- (2010) Folkert Steinhagen et al. VACCINE
- IL-12p40 and IL-18 Play Pivotal Roles in Orchestrating the Cell-Mediated Immune Response to a Poxvirus Infection
- (2009) Y. Wang et al. JOURNAL OF IMMUNOLOGY
- A single-dose combination therapy that both prevents and treats anthrax infection
- (2009) Dennis M. Klinman et al. VACCINE
- The measurement of serum ceruloplasmin is useful for diagnostic differentiation of immune thrombocytopenic purpura
- (2008) Mitsuhiro Chousa et al. CLINICA CHIMICA ACTA
- Role of V 14+ NKT cells in the development of Hepatitis B virus-specific CTL: activation of V 14+ NKT cells promotes the breakage of CTL tolerance
- (2008) H. Ito et al. INTERNATIONAL IMMUNOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started